Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
33,651,643
-
Shares change
-
+1,228,313
-
Total reported value, excl. options
-
$207,371,526
-
Value change
-
+$5,868,022
-
Put/Call ratio
-
7.4%
-
Number of buys
-
52
-
Number of sells
-
45
-
Price
-
$6.09
Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q1 2022
As of 31 Mar 2022 Altimmune, Inc. - Common Stock (ALT) had 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,651,643 shares of stock of the company.
Largest 10 holders included Nuveen Asset Management, LLC, BlackRock Inc., Avidity Partners Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, ARDSLEY ADVISORY PARTNERS LP, SPHERA FUNDS MANAGEMENT LTD., BARCLAYS PLC, and CITADEL ADVISORS LLC.
This table shows 129 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.